Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO

SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the execution of a collaboration letter of intent between Kubota Vision and AUROLAB (Madurai, India). The purpose of the agreement is for Kubota Vision to provide AUROLAB with an exclusive license for product development, manufacturing, and distribution of eyeMO (P